LiftmyCVLiftmyCV
SM

VP, Nonclinical Development

Slate MedicinesOn-siteRaleigh, US

Job description

About Slate Medicines Slate Medicines is a clinical-stage biotech company developing next-generation therapeutics for migraine and other headache disorders. Its lead program, SLTE-1009, is a subcutaneous monoclonal antibody targeting both PACAP and VIP, with the potential to be a best-in-class option for migraine prevention; the program entered Phase 1 in 2026, with topline data expected in mid-2027 and a Phase 2 start planned for 2027. Slate is backed by leading healthcare investors including RA Capital Management, Forbion, Foresite Capital, and Frazier Life Sciences, and is on track to become a publicly traded company (Nasdaq: SLTE) through a planned merger with Fulcrum Therapeutics. The Opportunity Slate Medicines is seeking a VP, Nonclinical Development to lead nonclinical strategy and execution across the company's pipeline. The VP will own nonclinical development for Slate's lead clinical-stage biologic, a dual PACAP/VIP-targeting monoclonal antibody currently in Phase 1, as well as an emerging antibody program moving through discovery and preclinical development. The role is accountable for pharmacology, toxicology, and bioanalytical/DMPK strategy across the portfolio, for the nonclinical content of regulatory submissions, and for managing the external CRO and CDMO network the function depends on. E Key Responsibilities

  • Set and execute nonclinical strategy across pharmacology, toxicology, and bioanalytical/DMPK for all active programs, aligning study design with clinical and regulatory timelines.
  • Own the nonclinical sections of INDs, Investigator's Brochures, and other regulatory submissions, and represent nonclinical data directly to health authorities as needed.
  • Design and oversee GLP toxicology packages (repeat-dose, dose-range-finding, tissue cross-reactivity, immunogenicity/Fc-receptor characterization) for biologics programs, including life-cycle studies (e.g., carcinogenicity, juvenile toxicology) as the pipeline matures.
  • Manage the external CRO/CDMO network supporting nonclinical work, including toxicology labs, bioanalytical vendors, and an international originator/CDMO relationship: covering vendor selection, contracting, study oversight, and data quality.
  • Partner cross-functionally with Regulatory Affairs, Quality/GLP Compliance, CMC, and Clinical Development to ensure nonclinical data packages support program milestones and inspection readiness.
  • Lead nonclinical due diligence for in-licensing or business development opportunities, including assessment of external pharmacology and toxicology packages.
  • Build and lead the internal nonclinical function, including hiring and managing future staff as the team scales with the pipeline.

Job details

Published
November 5, 2026
Job source
jworkable
Workplace
On-site · Raleigh, US
First seen
November 5, 2026
AI match explained

See how well you match this job

Log in or sign up and Eva will compare your profile with this role, explain your strengths and show what to improve.

Sign up to see your matchAlready have an account? Log in

More at Slate Medicines

Similar jobs from this company

Across the market

Similar jobs from other companies

Related job searches

Third-party content disclaimer

Full job descriptions are sourced directly from third-party applicant tracking systems (ATS), job boards, recruitment platforms, and employer career pages.

LiftmyCV does not claim ownership of this content or guarantee its accuracy or current availability. All original content is the intellectual property of the respective employers or other rights holders.

LiftmyCV hiring intelligence, availability checks, and related-job recommendations are generated from LiftmyCV data and public sources.

If you prefer, you may apply directly via the original listing for transparency.